News

July 1, 2010 – Clinical results have shown the Rheos System is successful in lowering blood pressure, CVRx Inc. announced this week at the European Society of Hypertension Meeting. The system is...

June 21, 2010 – Long-term data presented today from Ardian’s Symplicity HTN-1 study demonstrate that the significant reductions in blood pressure achieved using renal denervation (RDN) treatment...

June 15, 2010 – Health care professionals can now get information on the diagnosis, pathology, and treatment of pulmonary arterial hypertension (PAH) on their smart phones. Actelion...

April 22, 2010 — An improved formulation of epoprostenol for the treatment of primary pulmonary arterial hypertension (PAH) and pulmonary hypertension is now commercially available.

April 19, 2010 – The U.S. Food and Drug Administration (FDA) recently cleared a generic version of metoprolol succinate extended-release tablets. The beta-blocker is used to treat angina, heart...

March 23, 2010 – The FDA granted approval for diltiazem hydrochloride extended-release tablets to treat hypertension, which is the generic equivalent to Biovail Laboratories International SRL's...

March 16, 2010 — Lowering blood pressure to normal levels — below currently recommended levels — did not significantly reduce the combined risk of fatal or nonfatal cardiovascular disease events...

March 3, 2010 – Pharmaceutical companies will struggle to profit from the cardiovascular disease (CVD) market over the next decade despite growing drug usage, according to new market research from...

January 21, 2010 – A new minimally invasive therapy using radiofrequency ablation to short-circuit nerves in the kidney arteries shows promise in treating uncontrolled hypertension. The research...

January 21, 2010 - A recent study found generic epoprostenol is a safe and effective therapy alternative to brand name Flolan for patients suffering from pulmonary arterial hypertension (PAH).

January 11, 2010 – A hypertension drug using a combination of telmisartan/amlodipine, which requires less-frequent dosing than Novartis's Diovan/Tareg (valsartan), may earn 30 percent patient...

November 23, 2009 – The U.S. Food and Drug Administration (FDA) Nov. 20 approved Revatio (sildenafil) Injection, an intravenous formulation of Revatio, for the treatment of adult patients with...

October 15, 2009 – A study conducted by the University of Rochester Medical Center (URMC) demonstrates that, for certain patient populations, an experimental device that lowers blood pressure may...

June 21, 2007 - Exforge, a single-tablet combination of two of the most prescribed high blood pressure medicines, has been granted final FDA approval for use in patients who suffer from high blood...